4516 日本新薬 企業サイト Yahooファイナンス 日経新聞 株探 四季報
基本データ
【業種】医薬品【市場】プライム（内国株式）
【決算期】3月
【会社設立】1919.10
【上場】1949.6
【直近決算日】2024-11-13
【決算予定日】
【時価総額】2822億7000万円
【予想PER】9.02 倍
【PBR】1.15 倍
【自己資本比率】87.5 %
業績予想（通期のみ）
| 年度 | タイプ | 日付 | 売上高 | 営業利益 | 経常利益 | 純利益 |
|---|---|---|---|---|---|---|
| 2022-03 | 新規 | 2022-05-11 | 134000 | 27000 | 27500 | 21500 |
| 2023-03 | 新規 | 2022-06-30 | 134000 | 27000 | 27500 | 21500 |
| 修正 | 2022-11-10 | 141000(↑) | 30000(↑) | 30400(↑) | 24000(↑) | |
| 2024-03 | 新規 | 2023-05-11 | 145000 | 32000 | 32500 | 25000 |
| 修正 | 2023-11-13 | 147000(↑) | 33500(↑) | 34000(↑) | 26000(↑) | |
| 2025-03 | 新規 | 2024-05-10 | 150000 | 31000 | 31500 | 24500 |
| 修正 | 2024-08-07 | 154000(↑) | 32000(↑) | 32500(↑) | 29000(↑) | |
| 修正 | 2024-11-13 | 157000(↑) | 33000(↑) | 33600(↑) | 30000(↑) |
※来期予想のグラフはQ1と表記されているがQ4である。
| 決算期 | 四半期 | 売上高 | 営業利益 | 経常利益 | 純利益 | 1株当たり純利益 | 営業利益率 | 経常利益率 | 売上高/前年比 | 営業利益/前年比 | 経常利益/前年比 | 純利益/前年比 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 予想 | 157000 | 33000 | 33600 | 30000 | 21.02% | 21.4% | 5.9% | -0.9% | -0% | 16% | ||
| 2025-03 | 2 | 79332 | 17867 | 18198 | 16373 | 243.09 | 22.52% | 22.94% | 8.2% | -14.4% | -13.9% | 1.2% |
| 1 | 39131 | 11078 | 11411 | 10264 | 152.4 | 28.31% | 29.16% | 5.7% | -0.8% | -0.3% | 17.3% | |
| 2024-03 | 4 | 148255 | 33295 | 33616 | 25851 | 383.82 | 22.46% | 22.67% | 2.8% | 10.8% | 10.3% | 13.3% |
| 3 | 112728 | 30450 | 30973 | 24002 | 356.37 | 27.01% | 27.48% | 2.6% | 8.8% | 9% | 5.9% | |
| 2 | 73314 | 20878 | 21146 | 16176 | 240.17 | 28.48% | 28.84% | 3.1% | 9% | 9% | 6.2% | |
| 1 | 37012 | 11163 | 11440 | 8751 | 129.91 | 30.16% | 30.91% | 3.9% | 8.6% | 8.8% | 6% | |
| 2023-03 | 4 | 144175 | 30049 | 30489 | 22819 | 338.7 | 20.84% | 21.15% | 4.9% | -8.8% | -8.4% | -8.7% |
| 3 | 109919 | 27987 | 28422 | 22681 | 336.65 | 25.46% | 25.86% | 3.4% | -7.8% | -7.5% | -1.7% | |
| 2 | 71136 | 19161 | 19398 | 15228 | 226.01 | 26.94% | 27.27% | -0.6% | -12.1% | -11.9% | -7.9% | |
| 1 | 35619 | 10276 | 10514 | 8253 | 122.48 | 28.85% | 29.52% | -13.1% | -37.9% | -37.3% | -34.5% | |
| 2022-03 | 4 | 137547 | 28299 | 29773 | 23044 | 342.14 | 20.57% | 21.65% | 12.8% | 8.3% | 11.3% | 11.3% |
| 3 | 106218 | 29321 | 30563 | 22606 | 335.64 | 27.6% | 28.77% | 15.7% | 44% | 45.4% | 49.9% | |
| 2 | 71568 | 21504 | 22250 | 16561 | 245.89 | 30.05% | 31.09% | 23.8% | 93% | 97.8% | 105.1% | |
| 1 | 41157 | 16448 | 16598 | 12341 | 183.24 | 39.96% | 40.33% | 37.6% | 118.6% | 114.9% | 111.5% | |
| 2021-03 | 4 | 121885 | 26134 | 26760 | 20702 | 307.37 | 21.44% | 21.96% | 4.5% | 20.6% | 19.2% | 22.7% |
| 3 | 91837 | 20362 | 21023 | 15085 | 223.97 | 22.17% | 22.89% | 4.2% | 31.7% | 29.2% | 26.9% | |
| 2 | 57817 | 11140 | 11248 | 8073 | 119.87 | 19.27% | 19.45% | 0.8% | 1% | -0.2% | -2.6% | |
| 1 | 29913 | 7522 | 7723 | 5835 | 86.64 | 25.15% | 25.82% | 1.8% | 16.6% | 17.3% | 17.9% | |
| 2020-03 | 4 | 116637 | 21668 | 22442 | 16866 | 250.42 | 18.58% | 19.24% | 1.7% | 5% | 4.2% | 3.5% |
| 3 | 88113 | 15466 | 16277 | 11886 | 176.47 | 17.55% | 18.47% | 1.3% | -5.9% | -5.6% | -6.4% | |
| 2 | 57387 | 11025 | 11271 | 8291 | 123.11 | 19.21% | 19.64% | 7.3% | 45.7% | 37.5% | 37.3% | |
| 1 | 29391 | 6453 | 6585 | 4951 | 73.51 | 21.96% | 22.4% | 5.7% | 33.1% | 23.8% | 24.9% | |
| 2019-03 | 4 | 114716 | 20644 | 21540 | 16302 | 242.04 | 18% | 18.78% | 13.1% | 20.9% | 23.4% | 25.9% |
| 3 | 87019 | 16435 | 17244 | 12698 | 188.52 | 18.89% | 19.82% | 12% | 7.1% | 7.9% | 8.9% | |
| 2 | 53497 | 7569 | 8196 | 6037 | 89.64 | 14.15% | 15.32% | 7.7% | -18.3% | -15.3% | -13.7% |